Trellus Health plc
TRLHF
$0.02
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 552.73% | 539.19% | 500.00% | 312.20% | 150.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 552.73% | 539.19% | 500.00% | 312.20% | 150.00% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 552.73% | 539.19% | 500.00% | 312.20% | 150.00% |
| SG&A Expenses | 4.24% | 13.72% | 23.76% | 4.22% | -12.03% |
| Depreciation & Amortization | 23.27% | 23.27% | 23.27% | 25.81% | 29.10% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.14% | 14.70% | 23.70% | 6.08% | -9.14% |
| Operating Income | -1.76% | -11.81% | -22.33% | -5.20% | 9.60% |
| Income Before Tax | -3.38% | -12.83% | -22.76% | -4.10% | 11.60% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.38% | -12.83% | -22.76% | -4.10% | 11.60% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.38% | -12.83% | -22.76% | -4.10% | 11.60% |
| EBIT | -1.76% | -11.81% | -22.33% | -5.20% | 9.60% |
| EBITDA | -1.87% | -11.98% | -22.56% | -5.26% | 9.29% |
| EPS Basic | -3.40% | -12.69% | -22.45% | -3.96% | 11.59% |
| Normalized Basic EPS | -7.26% | -16.94% | -27.12% | -4.98% | 13.29% |
| EPS Diluted | -3.40% | -12.69% | -22.45% | -3.96% | 11.59% |
| Normalized Diluted EPS | -7.26% | -16.94% | -27.12% | -4.98% | 13.29% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |